Anakinra treatment in patients with gout and type 2 diabetes.

Vitale, Antonio

Anakinra treatment in patients with gout and type 2 diabetes. [electronic resource] - Clinical rheumatology May 2015 - 981-4 p. digital

Publication Type: Case Reports; Journal Article

1434-9949

10.1007/s10067-014-2601-7 doi


Aged
Aged, 80 and over
Allopurinol--therapeutic use
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Antirheumatic Agents--therapeutic use
Blood Glucose--metabolism
Carbamates--therapeutic use
Colchicine--therapeutic use
Diabetes Mellitus, Type 2--complications
Febuxostat--therapeutic use
Glycated Hemoglobin--metabolism
Gout--complications
Gout Suppressants--therapeutic use
Humans
Hyperuricemia--blood
Hypoglycemic Agents--therapeutic use
Insulin--therapeutic use
Interleukin 1 Receptor Antagonist Protein--therapeutic use
Metformin--therapeutic use
Middle Aged
Piperidines--therapeutic use
Treatment Outcome
Uric Acid--blood